The trajectory of Viagra presents a nuanced case for observers in the pharmaceutical sector. While initially a blockbuster success, creating vast sums, the intellectual property lapse and the subsequent arrival of generic versions have considerably affected earnings. This presents questions about the long-term profitability of analogous therapeu… Read More